Table 1 List of autoimmune diseases and autoantibodies associated with SARS-CoV-2 infection
From: Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2
| Autoimmune disorder secondary to SARS-CoV-2 infection | Autoantibodies detected in COVID-19 patients |
|---|---|
| Antiphospholipid syndrome | Antiphosphatidylserine IgM/IgG |
| Immune thrombocytopaenic purpura | Anti-SSA autoantibody |
| Guillain-Barré syndrome | Anti-globulin antibodies |
| Cold agglutinin disease & autoimmune | Anti-nuclear antibodies (ANA) |
| Systemic lupus erythematosus (SLE) | Anti-cardiolipin (aCL) antibodies |
| Miler Fisher Syndrome (MFS) | Anti-MDA5 antibodies |
| Kawasaki disease | Anti-β2 glycoprotein 1 antibodies |
| NMDA-receptor encephalitis | LAC –lupus anticoagulant |
| Subacute thyroiditis | Antiprothrombin IgM |
| Graves’ disease | Anti-GD1b antibodies |
| Sarcoidosis | Anti-CCP antibodies |
| Myasthenia gravis | Anti-heparin PF4 complex antibody |
| Hemolytic anemia | Antiannexin V IgM/IgG |
| Neuromyelitis optica | pANCA AND cANCA |
| Large vessel vasculitis & thrombosis | |
| Type I diabetes | |
| Psoriasis |